Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes
Erica P. Cai(Joslin Diabetes Center), Yi Peng(Joslin Diabetes Center), Celia A. Schiffer(University of Massachusetts Chan Medical School), Douglas A. Melton(Howard Hughes Medical Institute), Neşe Kurt Yılmaz(University of Massachusetts Chan Medical School), Nayara C. Leite(Universidade Estadual de Campinas (UNICAMP)), Shurong Hou(University of Massachusetts Chan Medical School), Badr Kiaf(Joslin Diabetes Center), Stephan Kissler(Joslin Diabetes Center), Jian Li(Second Hospital of Tianjin Medical University), Wei Zhang(University of Akron), Jennifer Hollister‐Lock(Joslin Diabetes Center), Yuki Ishikawa(Joslin Diabetes Center)
Cited by 98
Related Papers
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
|Proceedings of the National Academy of Sciences|2000|1.1k
Generation of stem cell-derived β-cells from patients with type 1 diabetes
|Nature Communications|2016|384
Co-ordinated ocular development from human iPS cells and recovery of corneal function
|Nature|2016|255
Geometry induced sequence of nanoscale Frank–Kasper and quasicrystal mesophases in giant surfactants
|Proceedings of the National Academy of Sciences|2016|245